<s>[INST] The next text is a question of a member of the European parliament:"The EU is providing EUR 12 million to fund a five-year project for the development of medicinal products and vaccines using genetically modified plants. The aim is to obtain active substances to be used to combat AIDS, diabetes and tuberculosis by isolating genes for those substances and inserting them into plants.  1.Can the Commission indicate total EU expenditure on the development of pharmaceutical substances using genetically modified organisms and compare it with expenditure on the promotion of natural medicines?  2.For what percentage of total funding for pharmaceutical research do these two amounts account?"
Analyze carefully the text and assign it to the most relevant policy area among those listed below. Do not explain your answer and return only a number.
Policy area numbers: 1 = Macroeconomics
2 = Civil Rights, Minority Issues and Civil Liberties
3 = Health
4 = Agriculture and Fisheries
5 = Labour, employment and pensions
6 = Education
7 = Environment
8 = Energy
9 = Immigration
10 = Transportation
12 = Law and Crime
13 = Social welfare
14 = Regional and Urban issues and Planning
15 = Banking, finance and domestic commerce issues
16 = Defence
17 = Space, science, technology, and communications issues
18 = Foreign trade
19 = International affairs and foreign aid
20 = Governance and government
21 = Public Lands, Water Management and Territorial Issues
23 = Culture and media
[/INST]. Answer = [3]. </s>
The EU is providing EUR 12 million to fund a five-year project for the development of medicinal products and vaccines using genetically modified plants. The aim is to obtain active substances to be used to combat AIDS, diabetes and tuberculosis by isolating genes for those substances and inserting them into plants.  1.Can the Commission indicate total EU expenditure on the development of pharmaceutical substances using genetically modified organisms and compare it with expenditure on the promotion of natural medicines?  2.For what percentage of total funding for pharmaceutical research do these two amounts account?